Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial
Lisse Decraecker(KU Leuven), Guy E. Boeckxstaens(KU Leuven), Albert J. Bredenoord(Amsterdam Neuroscience), Philip Caenepeel(Universitair Ziekenhuis Leuven), Willy Peetermans(KU Leuven), Danny De Looze(Ghent University Hospital), Alexandre Denadai‐Souza(Université Toulouse III - Paul Sabatier), Kim Van Beek(Universitair Ziekenhuis Leuven), Ann Belmans(KU Leuven), Tim Vanuytsel(Universitair Ziekenhuis Leuven), Jeroen J. Kolkman(Medisch Spectrum Twente), Koen Bellens(Universitair Ziekenhuis Leuven), Fedrica Pia(KU Leuven), Joris Arts(Universitair Ziekenhuis Leuven), David P. Hirsch(Amsterdam UMC Location University of Amsterdam), Heiko U. De Schepper(Antwerp University Hospital)
Cited by 37
Related Papers
A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment
|Nature Neuroscience|2019|1.1k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
|Thorax|2013|861
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
|European Journal of Vascular and Endovascular Surgery|2017|641